Apremilast Treatment Outcomes and Adverse Events in Psoriasis Patients With HIV

被引：0
作者：
Lauck, Kyle C. [1 ,2 ]
Nguyen, Kaycee [5 ]
Columbus, Cristie [1 ,3 ,4 ]
Tolkachjov, Stanislav N. [2 ,6 ,7 ]
机构：
[1] Baylor Univ, Med Ctr, Dallas, TX USA
[2] Texas A&M Univ, Dept Dermatol, College Stn, TX USA
[3] Texas A&M Univ, Div Infect Dis, College Stn, TX USA
[4] Texas A&M Univ, Dept Internal Med, College Stn, TX USA
[5] Texas A&M Univ, Coll Med, College Stn, TX USA
[6] Epiphany Dermatol, Dallas, TX USA
[7] Univ Texas Southwestern Med Ctr, Dept Dermatol, Dallas, TX USA
来源：
CUTIS | 2024年 / 115卷 / 02期
关键词：
D O I：
10.12788/cutis.1166
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
引用
收藏
页数：3
相关论文
共 13 条
[1]   Long-term safety and tolerability of apremilast in patients with psoriasis: Pooled safety analysis for ≥156 weeks from 2 phase 3, randomized, controlled trials (ESTEEM 1 and 2) [J].
Crowley, Jeffrey ;
Thaci, Diamant ;
Joly, Pascal ;
Peris, Ketty ;
Papp, Kim A. ;
Goncalves, Joana ;
Day, Robert M. ;
Chen, Rongdean ;
Shah, Kamal ;
Ferrandiz, Carlos ;
Cather, Jennifer C. .
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2017, 77 (02) :310-+
[2]   Psoriasis: Which therapy for which patient Focus on special populations and chronic infections [J].
Kaushik, Shivani B. ;
Lebwohl, Mark G. .
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2019, 80 (01) :43-53
[3]   Apremilast efficacy and safety in a psoriatic arthritis patient affected by HIV and HBV virus infections [J].
Manfreda, Valeria ;
Esposito, Maria ;
Campione, Elena ;
Bianchi, Luca ;
Giunta, Alessandro .
POSTGRADUATE MEDICINE, 2019, 131 (03) :239-240
[4]   Global Epidemiology of Psoriasis: A Systematic Review of Incidence and Prevalence [J].
Parisi, Rosa ;
Symmons, Deborah P. M. ;
Griffiths, Christopher E. M. ;
Ashcroft, Darren M. .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2013, 133 (02) :377-385
[5]   Psoriasis prevalence among adults in the United States [J].
Rachakonda, Tara D. ;
Schupp, Clayton W. ;
Armstrong, April W. .
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2014, 70 (03) :512-516
[6]   Apremilast for a psoriasis patient with HIV and hepatitis C [J].
Reddy, S. P. ;
Shah, V. V. ;
Wu, J. J. .
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2017, 31 (11) :E481-E482
[7]  
Reddy SP, 2019, CUTIS, V103, pE6
[8]   Successful treatment with secukinumab in an HIV-positive psoriatic patient after failure of apremilast [J].
Romita, Paolo ;
Foti, Caterina ;
Calianno, Gianluca ;
Chiricozzi, Andrea .
DERMATOLOGIC THERAPY, 2022, 35 (08)
[9]   Apremilast as therapeutic option in a HIV positive patient with severe psoriasis [J].
Sacchelli, Lidia ;
Patrizi, Annalisa ;
Ferrara, Francesca ;
Bardazzi, Federico .
DERMATOLOGIC THERAPY, 2018, 31 (06)
[10]   Apremilast mechanism of action and application to psoriasis and psoriatic arthritis [J].
Schafer, Peter .
BIOCHEMICAL PHARMACOLOGY, 2012, 83 (12) :1583-1590
12